Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

YiHong Wang

Showing results (231-240 of 245) with videos related to

Pageof 25
Sort By:
BMJ Open|October 27, 2021
Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort studyThomas E Rohan, Mindy Ginsberg, Yihong Wang, et al.
Plos One|September 21, 2011
Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapyLuiz F Zerbini, Rodrigo E Tamura, Ricardo G Correa, et al.
Cancer Research|December 21, 2006
A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cellsLuiz F Zerbini, Akos Czibere, Yihong Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2004
NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survivalLuiz F Zerbini, Yihong Wang, Akos Czibere, et al.
Biomedical Reports|August 15, 2017
The relationship between tumor necrosis factor-α polymorphisms and gastric cancer risk: An updated meta-analysisWenxian Zheng, Shuisheng Zhang, Shenfeng Zhang, et al.
Breast Cancer Research : BCR|March 19, 2021
Risk factors for breast cancer development by tumor characteristics among women with benign breast diseaseJonine D Figueroa, Gretchen L Gierach, Máire A Duggan, et al.
Breast Cancer Research : BCR|February 13, 2010
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic featuresNadine Tung, Yihong Wang, Laura C Collins, et al.
International Journal of Molecular Sciences|March 25, 2017
Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE SpecimensOlivier Loudig, Tao Wang, Kenny Ye, et al.
BMC Cancer|December 8, 2020
Cancer patient management strategy in a Cancer Center of Zhejiang, China during the COVID-19 pandemicSongxiao Xu, Xiangdong Cheng, Zhiwen Pan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 8, 2019
Two types of primary mucinous ovarian tumors can be distinguished based on their originMichiel Simons, Femke Simmer, Johan Bulten, et al.
Pageof 25

Showing results (231-240 of 245) with videos related to

Sort By:
Pageof 25
BMJ Open|October 27, 2021
Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort studyThomas E Rohan, Mindy Ginsberg, Yihong Wang, et al.
Plos One|September 21, 2011
Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapyLuiz F Zerbini, Rodrigo E Tamura, Ricardo G Correa, et al.
Cancer Research|December 21, 2006
A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cellsLuiz F Zerbini, Akos Czibere, Yihong Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2004
NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survivalLuiz F Zerbini, Yihong Wang, Akos Czibere, et al.
Biomedical Reports|August 15, 2017
The relationship between tumor necrosis factor-α polymorphisms and gastric cancer risk: An updated meta-analysisWenxian Zheng, Shuisheng Zhang, Shenfeng Zhang, et al.
Breast Cancer Research : BCR|March 19, 2021
Risk factors for breast cancer development by tumor characteristics among women with benign breast diseaseJonine D Figueroa, Gretchen L Gierach, Máire A Duggan, et al.
Breast Cancer Research : BCR|February 13, 2010
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic featuresNadine Tung, Yihong Wang, Laura C Collins, et al.
International Journal of Molecular Sciences|March 25, 2017
Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE SpecimensOlivier Loudig, Tao Wang, Kenny Ye, et al.
BMC Cancer|December 8, 2020
Cancer patient management strategy in a Cancer Center of Zhejiang, China during the COVID-19 pandemicSongxiao Xu, Xiangdong Cheng, Zhiwen Pan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 8, 2019
Two types of primary mucinous ovarian tumors can be distinguished based on their originMichiel Simons, Femke Simmer, Johan Bulten, et al.
Pageof 25